Adaptive Biotechnologies Corporation (DUS:1HM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Hershberg Other companies: Danaher Corporation (Director · Since at least Nov 15, 2026); AtaiBeckley Inc. (Director · Since at least Jun 4, 2026); Hillevax Inc (President and CEO, Director · Since at least Apr 28, 2022); Recursion Pharmaceuticals, Inc. (Board Member · Since at least Apr 15, 2021); ARS Pharmaceuticals, Inc. (Director · Dec 3, 2020 – Jun 10, 2022 · Past); Fate Therapeutics, Inc. (Director · May 1, 2020 – Jun 6, 2023 · Past); NanoString Technologies Inc (Director · Mar 2, 2015 – Apr 18, 2022 · Past); Dendreon Corp (Sr. VP & Chief Medical Officer · Dec 31, 2005 – Jan 19, 2006 · Past) | Board Member · Since at least Jun 26, 2019 |
| Kevin T Conroy Other companies: Abbott Laboratories (Director · Since at least Apr 24, 2026); American Exceptionalism Acquisition Corp. A (Director · Since at least Sep 25, 2025); Align Technology, Inc. (Director · Since at least Dec 5, 2023); EXACT Sciences Corporation (President and CEO, Director · Since at least Mar 18, 2009); ARYA Sciences Acquisition Corp (Director · Oct 5, 2018 – Jul 1, 2020 · Past); Epizyme Inc (Director · Feb 6, 2017 – Aug 12, 2022 · Past) | Director · Jun 26, 2019 – Mar 6, 2023 · Past |
| Eric Dobmeier Other companies: Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Janux Therapeutics, Inc. (Director · Since at least Jul 19, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Aduro Biotech Inc (President, CEO, Director · Oct 5, 2020 – Aug 11, 2023 · Past); Atara Biotherapeutics, Inc. (Director · Jun 27, 2019 – Nov 10, 2023 · Past) | Director · Jun 26, 2019 – Feb 14, 2021 · Past |
| Chad Cohen Other companies: Grindr Inc. (Director · Since at least Jul 30, 2024); Vacasa Inc (Director · Dec 7, 2021 – Apr 30, 2025 · Past); Trupanion, Inc. (Director · Dec 7, 2015 – Mar 31, 2019 · Past); Zillow Group, Inc. (CFO & Treasurer · Mar 1, 2011 – Feb 17, 2015 · Past) | Chief Financial Officer · Jun 26, 2019 – Dec 22, 2021 · Past |
| David E Goel Other companies: Alumis Inc. (Director · Jun 27, 2024 – May 21, 2025 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Zentalis Pharmaceuticals, Inc. (Director · Apr 3, 2020 – Apr 3, 2020 · Past); Popular, Inc. (Director · Feb 12, 2012 – May 8, 2018 · Past) | Director · Jun 26, 2019 – Feb 15, 2021 · Past |
| Leslie Trigg Other companies: EXACT Sciences Corporation (Director · Since at least Apr 29, 2025); Outset Medical, Inc. (Chair and CEO · Since at least Aug 17, 2020); ARYA Sciences Acquisition IV Corp (Director · Feb 25, 2021 – Jul 31, 2024 · Past); Cardiovascular Systems Inc (Director · Aug 31, 2012 – Nov 18, 2016 · Past) | Director · Mar 17, 2021 – Mar 6, 2023 · Past |
| Peter Neupert Other companies: Fortrea Holdings Inc. (Director · Since at least Jun 29, 2023); Labcorp Holdings Inc. (Director · Since at least Jan 1, 2013); Nextgen Healthcare Inc (Director · Aug 15, 2013 – Aug 15, 2013 · Past); Aquantive Inc (Director · May 10, 2006 – May 10, 2006 · Past) | Board Member · Since at least Jun 26, 2019 |
| Chad Robins Other companies: CM Life Sciences III Inc. (Director · Apr 6, 2021 – Apr 6, 2021 · Past); Cerevel Therapeutics Holdings Inc (Director · Jun 4, 2020 – Jun 4, 2020 · Past) | Chief Executive Officer, Co-founder, Chairman of the Board · Since at least Jun 26, 2019 |
| Michelle Griffin Other companies: Acer Therapeutics Inc (Director · Mar 14, 2023 – Mar 14, 2023 · Past); Aduro Biotech Inc (Director · May 26, 2022 – Aug 11, 2023 · Past) | Board Member · Since at least Mar 6, 2023 |
| Harlan S Robins Other companies: CM Life Sciences III Inc. (Director · Apr 6, 2021 – Apr 6, 2021 · Past) | Chief Scientific Officer · Since at least Jun 26, 2019 |
| Michael J Pellini Other companies: Singular Genomics Systems Inc (Director · May 29, 2024 – Feb 21, 2025 · Past) | Director · Mar 4, 2024 – Mar 4, 2025 · Past |
| ADAPTIVE INVESTORSKarina Calzadilla | Vice President, Investor Relations and FP& · Since at least Apr 15, 2026 |
| ADAPTIVE MEDIAErica Jones | Associate Corporate Communications · Since at least Apr 15, 2026 |
| Andris A Zoltners | Director · Jun 26, 2019 – Feb 13, 2020 · Past |
| Charles Sang | SVP, External Affairs · Jun 26, 2019 – Dec 11, 2020 · Past |
| Clarice McCauley | VP, Head of Legal · Since at least Nov 5, 2026 |
| Ed Moyle | Chief Information Security Officer · Dec 2, 2025 – Nov 5, 2026 · Past |
| Erica Jones | Associate Corporate Communications Director · Since at least Oct 14, 2026 |
| Francis Lo | Chief People Officer · Since at least Jun 26, 2019 |
| Jim Snook | Senior Vice President, Global Sales · Mar 5, 2026 – Nov 5, 2026 · Past |
| Jim Snook | Senior Vice President, Global Sales · Since Mar 5, 2026 · Appointed, no departure found |
| Julie Rubinstein | President & Chief Operating Officer · Since at least Jun 26, 2019 |
| Karina Calzadilla | Vice President, Investor Relations and FP&A · Since at least Oct 14, 2026 |
| Katey Owen | Board Member · Since at least Mar 17, 2021 |
| Kyle Piskel | Chief Financial Officer · Since at least Jun 26, 2019 |
| Lance Baldo | Chief Medical Officer · Jun 26, 2019 – Mar 8, 2022 · Past |
| Mary Pat Lancelotta | Senior Vice President, Global Market and Business Development · Since at least Jun 30, 2026 |
| Nancy Louise Hill | EVP, Operations & Program Mana · Jun 26, 2019 – Jan 19, 2021 · Past |
| Nitin Sood | Chief Commercial Officer, MRD · Aug 4, 2021 – Aug 7, 2023 · Past |
| R Mark Adams | Chief Operating Officer · Apr 6, 2020 – Apr 10, 2023 · Past |
| Sharon Benzeno | Chief Commercial Officer, Immune Medicine · Since at least Jun 26, 2019 |
| Stacy L Taylor | SVP and General Counsel · Jan 8, 2020 – Aug 22, 2024 · Past |
| Susan Bobulsky | Chief Commercial Officer, MRD · Since at least Aug 6, 2020 |
| Tycho Peterson | Chief Financial Officer · Jun 1, 2022 – Mar 4, 2024 · Past |